GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Herantis Pharma PLC (OHEL:HRTIS) » Definitions » FFO

Herantis Pharma (OHEL:HRTIS) FFO


View and export this data going back to 2014. Start your Free Trial

What is Herantis Pharma FFO?

FFO (Funds from operations) only applies to REITs.


Herantis Pharma Business Description

Traded in Other Exchanges
N/A
Address
Bertel Jungin Aukio 1, Espoo, FIN, 02600
Herantis Pharma PLC is a biotech company developing disease-modifying therapies for Parkinson's disease. The company's current development program focuses solely on HER-096, which is a peptidomimetic molecule designed to retain the biological activity of the neuroprotective CDNF protein.